Muscular dystrophy drug approval 'recommended' in EU

May 24, 2014 1:33 AM

2 0

Muscular dystrophy drug approval 'recommended' in EU

A drug to treat a particular form of Duchenne muscular dystrophy has been given the green light by the European Medicines Agency and could be available in the UK in six months.

Translarna is only relevant to patients with a 'nonsense mutation', who make up 10-15% of those affected by Duchenne.

Read more

To category page

Loading...